Diagnosis of synovial sarcoma of the pleura and differentiation from malignant mesothelioma

Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies

Volumn , Issue , 2005, Pages 543-554

  Powers, Amy ^a   Carbone, Michele ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748793559     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-28274-2_36     Document Type: Chapter

References (21)

1. Weiss SW, Goldblum JR, eds. Soft Tissue Tumors, 4th ed. St. Louis: Mosby, 2001.
2. Aubry MC, Bridge JA, Wickert R, Tazelaar HD. Primary monophasic synovial sarcoma of the pleura. Am J Surg Pathol 2001;25:776-781.
3. Jawahar DA, Vuletin JC, Gorecki P, Persechino F, Macera M, Magazeh P. Primary biphasic synovial sarcoma of the pleura. Respir Med 1997;91:568-570.
4. Gaertner E, Zeren H, Fleming M, Colby T, Travis W. Biphasic synovial sarcomas arising in the pleural cavity. A clinicopathologic study of five cases. Am J Surg Pathol 1996;20:36-45.
5. Nicholson AG, Goldstraw P, Fisher C. Synovial sarcoma of the pleura and its differentiation from other primary pleural tumors: a clinicopathological and immunohistochemical review of three cases. Histopathology 1998;33:508-513.
6. Colwell AS, D'Cunta J, Vargas S, et al. Synovial sarcoma of the pleura: a clinical and pathologic study of three cases. J Thorac Cardiovasc Surg 2002;124:828-832.
7. Essary LR, Vargas SO, Fletcher CD. Primary pleuropulmonary synovial sarcoma: reappraisal of a recently described anatomic subset. Cancer 2002;94:459-469.
8. Chan JA, McMenamin ME, Fletcher C D M. Synovial sarcoma in older patients: clinicopathological analysis of 32 cases with emphasis on unusual histological features. Histopathology 2003;43:72-83.
9. Hirano H, Kizaki T, Sashikata T, et al. Synovial sarcoma arising from the pleura: a case report with ultrastructural and immunohistochemical studies. Med Electron Microsc 2002;35:102-108.
10. Carbone M, Rizzo P, Powers A, et al. Molecular analyses, morphology and immunohistochemistry together differentiate pleural synovial sarcomas from mesotheliomas: clinical implications. Anticancer Res 2002;22:3443-3448.
11. Ng SB, Ahmed Q, Tien SL, et al. Primary pleural synovial sarcoma. A case report and review of the literature. Arch Pathol Lab Med 2003;127:85-90.
12. Cappello F, Barnes L. Synovial sarcoma and malignant mesothelioma of the pleura: review, differential diagnosis and possible role of apoptosis. Pathology 2001;33:142-148.
13. Battifora H, McCaughey W T E. Atlas of Tumor Pathology. Tumors of the Serous Membrane. Washington, DC: Armed Forces Institute of Pathology, 1995:17-89.
14. Folpe AL, Schmidt RA, Chapman D, Gown AM. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high grade malignant peripheral nerve sheath tumors. Am J Surg Pathol 1998;22:673-682.
15. Miettinen M, Limon J, Niezabitowski A, Lasota J. Calretinin and other mesothelioma markers in synovial sarcoma. Am J Surg Pathol 2001;25:610-617.
16. Amin KM, Litzky LA, Smythe WR, et al. Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am J Pathol 1995;146:344-356.
17. Gaffey MJ, Milles SE, Swanson PE, et al. Immunoreactivity for Ber-Ep4 in adenocarcinomas, adenomatoid tumors, and malignant mesotheliomas. Am J Surg Pathol 1992;18:593-599.
18. Sheibani K, Shin SS, Kezirian J, et al. Ber-Ep4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol 1991;15:779-784.
19. Kawai A, Woodruff J, Healey JH, et al. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 1998;228:153-160.
20. Nilsson G, Skytting B, Xie Y, et al. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome. Cancer Res 1999;59:3180-3184.
21. Pass HI, Robinson BW, Testa JR, Carbone M. Emerging translational therapies for mesothelioma. Chest 1999;116:455S-460S.